You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Radiation-induced Brain Necrosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Carcinoma Trial in Nanchang (Endostar)

Recruiting
  • Nasopharyngeal Carcinoma
  • Nanchang, Jiangxi, China
    Xiaochang Gong
Dec 15, 2021

Brain Tumor Trial in Boston (MRI)

Recruiting
  • Brain Tumor
  • MRI
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 18, 2022

Brain Metastases, Radiation Necrosis Trial in Amiens (early 18F-FDOPA uptake)

Recruiting
  • Brain Metastases
  • Radiation Necrosis
  • early 18F-FDOPA uptake
  • Amiens, Picardie, France
    CHU Amiens
Mar 9, 2023

Radiation-Induced Neurocognitive Decline Following SRS of Newly

Suspended
  • Brain Metastases
  • +3 more
    • Chapel Hill, North Carolina
      University of North Carolina at Chapel Hill, Department of Radia
    Oct 7, 2022

    Brain Tumor, Medulloblastoma Trial in Memphis ([18F]DPA714)

    Recruiting
    • Brain Tumor
    • Medulloblastoma
    • Memphis, Tennessee
      St.Jude Children's Research Hospital
    Aug 17, 2022

    Hypopituitarism, Radiotherapy-Induced Hypopituitarism, Brain Tumor Trial in Dublin (Dynamic testing of Pituitary Function)

    Not yet recruiting
    • Hypopituitarism
    • +2 more
    • Dynamic testing of Pituitary Function
    • Dublin, Ireland
    • +1 more
    Aug 22, 2023

    Brain Metastases, Radiation Necrosis, Recurrent Tumor Trial in Durham, Winston-Salem (Radiation Therapy, Steroid Therapy, Laser

    Recruiting
    • Brain Metastases
    • +3 more
    • Radiation Therapy
    • +2 more
    • Durham, North Carolina
    • +1 more
    Jun 23, 2022

    Brain Metastases Trial in Durham (MRI)

    Recruiting
    • Brain Metastases
    • MRI
    • Durham, North Carolina
      Duke University Health System
    Jul 13, 2022

    Invasive Malignant Tumor, Metastatic Malignant Tumor in the Brain Trial in Atlanta (Dynamic Susceptibility Contrast-MRI

    Recruiting
    • Invasive Malignant Neoplasm
    • Metastatic Malignant Neoplasm in the Brain
    • Dynamic Susceptibility Contrast-MRI (DSC-MRI)
    • Magnetic Resonance Imaging (MRI)
    • Atlanta, Georgia
    • +1 more
    Sep 1, 2021

    Cancer, Brain Tumors Trial in Salt Lake City (FLT-PET Imaging)

    Completed
    Has Results
    • Cancer
    • Brain Tumors
    • FLT-PET Imaging
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Sep 20, 2021

    Chemo-radiation Induced Nausea and Vomiting Trial in Durham (Rolapitant, Ondansetron)

    Completed
    • Chemo-radiation Induced Nausea and Vomiting
    • Durham, North Carolina
      The Preston Robert Tisch Brain Tumor Center at Duke
    Dec 12, 2022

    Brain Tumor, Recurrent, Adult Trial in Loma Linda (PET/CT with F-Fluciclovine (Axumin))

    Recruiting
    • Brain Tumor, Recurrent, Adult
    • PET/CT with F-Fluciclovine (Axumin)
    • Loma Linda, California
      Loma Linda University Cancer Center
    Sep 20, 2021

    Secondary Malignant Tumor of Brain and Cerebral Meninges Trial in Cleveland (18F-fluciclovine, PET/CT of the brain)

    Completed
    • Secondary Malignant Neoplasm of Brain and Cerebral Meninges
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
    May 3, 2021

    Brain Tumors, Nervous System Tumors, Cognition Disorders Trial in Winston-Salem (Armodafinil, )

    Completed
    Has Results
    • Brain Tumors
    • +3 more
    • Winston-Salem, North Carolina
      Wake Forest University Comprehensive Cancer Center
    Sep 7, 2021

    Diffuse Glioma, Radionecrosis of Brain, High Grade Glioma Trial (Chlorophyllin)

    Not yet recruiting
    • Diffuse Glioma
    • +3 more
    • (no location specified)
    Sep 4, 2023

    Laser Ablation After Stereotactic Radiosurgery

    Completed
    Has Results
    • Metastatic Brain Tumors
    • +3 more
      • New Haven, Connecticut
      • +6 more
      Aug 23, 2021

      Radiation Necrosis Trial in Lexington, Louisville (25% Mannitol, Low-dose Intra-arterial Bevacizumab)

      Completed
      Has Results
      • Radiation Necrosis
      • 25% Mannitol
      • Low-dose Intra-arterial Bevacizumab
      • Lexington, Kentucky
      • +1 more
      May 2, 2022

      Nasopharyngeal Carcinoma, Adverse Effect of Radiation Therapy, Brain Necrosis Trial in Guangzhou (bevacizumab, Corticosteroid)

      Completed
      Has Results
      • Nasopharyngeal Carcinoma
      • +2 more
      • Guangzhou, Guangdong, China
        Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
      Dec 19, 2018

      Brain Tumor, Brain Necrosis, Brain Metastases Trial in Cleveland (MRF in conjunction with IVIM MRI without contrast)

      Not yet recruiting
      • Brain Tumor
      • +2 more
      • MRF in conjunction with IVIM MRI without contrast
      • Cleveland, Ohio
        Cleveland Clinic Taussig Cancer Center
      Oct 20, 2023

      Brain Metastases, Radiosurgery Trial in Seoul (Magnetic resonance imaging (MRI), Diffusion-weighted MRI, Arterial spin labeling

      Not yet recruiting
      • Brain Metastases
      • Radiosurgery
      • Magnetic resonance imaging (MRI)
      • +3 more
      • Seoul, Korea, Republic of
        Asan Medical Center
      May 11, 2023

      Brain Metastases Trial in New York (18F-FCH PET Scan)

      Completed
      • Brain Metastases
      • 18F-FCH PET Scan
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Dec 15, 2022

      Brain Tumor, Brain Metastases, Brain Cancer Trial in Indianapolis, Portland (Reduced Dose SRS)

      Recruiting
      • Brain Tumor
      • +2 more
      • Reduced Dose SRS
      • Indianapolis, Indiana
      • +2 more
      Aug 29, 2022

      Patients Receiving Brain Radiation

      Recruiting
      • Brain Tumor Adult
        • Rochester, New York
          James P. Wilmot Cancer Center at University of Rochester Medical
        Feb 8, 2022

        Brain Metastases, HER2-positive Breast Cancer Trial (Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine)

        Not yet recruiting
        • Brain Metastases
        • HER2-positive Breast Cancer
        • Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine
        • (no location specified)
        Jan 10, 2023

        Glioma Trial in Ottawa (MR perfusion imaging)

        Completed
        • Glioma
        • MR perfusion imaging
        • Ottawa, Ontario, Canada
          The Ottawa Hospital
        Oct 7, 2021